“…A significant portion (~1200 bp, corresponding to nt 283-nt 1478 of gene segment-2 of prototype PBV GI strain PBV/Human/CHN/1-CHN-97/1997) of gene segment-2 of the mongoose PBV strains (strains PBV/Mongoose/KNA/M33/2017, PBV/Mongoose/KNA/M45/2017, PBV/Mongoose/KNA/ M46/2017, PBV/Mongoose/KNA/M58/2017, PBV/Mongoose/KNA/M67/2017 and PBV/Mongoose/ KNA/M72/2017) was amplified by two separate, overlapping RT-PCRs using published primers PBV 1.2FP and PicoB43, as well as primers PicoB25 and PBV 1.2RP (primer sequences are shown in supplementary material S1) [23,24]. The remaining 5 -portion of gene segment-2 of the 6 mongoose PBV strains, and the 3portion of gene segment-2 of a single mongoose PBV strain (strain M58) could be amplified using a modified non-specific primer-based amplification method with modifications as previously described (elaborated in supplementary material S2) [13,19]. A new reverse primer, designated as PBV-Con3 (5 -AAT GGT TTA CTG CAC CAT CTC-3 , nt 1665-nt 1644 of gene segment-2 of mongoose PBV strain M58), was designed from a short stretch of nt sequence that is conserved in the 3 -UTR of gene segment-2 of mongoose PBV strain M58 and PBV GI strains from other host species.…”